Vaccines linked to Guillain-Barre syndrome

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1164, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Guillain-Barre Syndrome: A Review

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 330-334

Bentham Science Publishers

Access to resources Recommend Favorite

Efalizumab: Guillain-Barre syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Infliximab: Guillain-Barre syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Infliximab: Guillain-Barre syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Hepatitis A vaccine: Guillain-Barre syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite